Globel Growth Measures

• Finding treatments and medical therapies utilizing the Cannabaceae plant family.
• Utilizing subsidiaries to acquire, control IP/Branding of Patents, Trademarks, Copyrights, and Licenses.
• Developing one of the largest genomics databases in the cannabis industry through comprehensive plant sequencing and gene expression analysis.
• Becoming an industry leader in the cannabis consumer products industry

• Expanding its genomic-driven cannabis-breeding program to accelerate the development of new, patentable strains.
• Researching, developing, validating, patenting, and producing new cannabis-derived compounds and formulations for the treatment of human and animal disease.
• Developing an international network of hemp and cannabis cultivation and extraction facilities.